Welcome to our dedicated page for Airsculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on Airsculpt Technologies stock.
AirSculpt Technologies, Inc. provides premium body contouring procedures through AirSculpt offices. Its AirSculpt method is a minimally invasive treatment for fat removal, skin tightening, targeted body sculpting, and fat transfer procedures that use a patient’s own fat cells.
Company news centers on operating results, same-center and same-store sales trends, case volume, revenue, adjusted EBITDA, guidance, marketing initiatives, new procedure categories, balance sheet activity, and governance changes. Updates also address the company’s positioning within aesthetics demand tied to GLP-1 use and its direct medical procedure services model.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
AirSculpt Technologies (NASDAQ: AIRS) has expanded its operations with the opening of two new centers in Austin, Texas, and Orange County, California, bringing its total to 24 locations across the U.S. and Canada. The new centers aim to meet the increasing demand for AirSculpt's patented body contouring procedures, which are known for their minimal invasiveness and quick recovery times. Over 40,000 procedures have already been performed, indicating a strong market presence. CEO Todd Magazine expressed enthusiasm about the expansion, highlighting the growing consumer interest in their premium services.
AirSculpt Technologies, Inc. (NASDAQ:AIRS) announced its fourth quarter and full year 2022 results, highlighting significant growth in case volume and revenue.
Fourth quarter case volume increased by 15.7% year-over-year, reaching 3,337, while revenue rose by 8.4% to $40.7 million. For the full year, case volume grew 18.2% to 13,063 and revenue surged 26.6% to $168.8 million. Despite a diluted loss per share of $(0.26), the company reported an adjusted net income of $0.37 per share. Looking ahead, AirSculpt expects revenues between $187 million and $192 million for 2023, driven by the opening of five new centers.
AirSculpt Technologies, Inc. (NASDAQ: AIRS) will report its fourth quarter 2022 financial results on March 10, 2023, before market open. A conference call is scheduled for 8:30 a.m. Eastern Time on the same day, accessible via phone or a live webcast on the company’s investor relations website. AirSculpt is a leading provider of body contouring procedures utilizing its proprietary AirSculpt® method, offering a premium consumer experience through minimally invasive fat removal. The company aims to deliver exceptional results to its patients, reflecting its commitment to quality care.
AirSculpt Technologies announces a leadership change with Todd Magazine appointed as the new CEO, effective at the end of January 2023. Dr. Aaron Rollins, the company's founder, moves to the role of Executive Chairman, focusing on strategic guidance. Magazine, with over 30 years of experience in retail and brand building, aims to leverage AirSculpt's proprietary technology to accelerate growth. The company maintains its full-year 2022 revenue guidance of $168-$170 million, indicating stable financial expectations moving forward.
AirSculpt® Technologies (NASDAQ: AIRS) is set to showcase the results of body contouring procedures performed on former Real Housewives stars Vicki Gunvalson and LeeAnne Locken via Instagram Live on December 15. The event will reveal their experiences documented through AirSculpt TV. Participants shared positive feedback about the quick recovery and transformative results from their AirSculpt treatments. With over 30,000 procedures performed, the company focuses on providing minimally invasive body contouring solutions through its Elite Body Sculpture brand.
AirSculpt Technologies (NASDAQ: AIRS) announces the opening of its first international Elite Body Sculpture location in London, set for the first half of 2023. This expansion aims to broaden its reach and enhance its premium body contouring services. The company plans to open a total of five new locations in 2023. Dr. Aaron Rollins, CEO, expressed enthusiasm for the London location, highlighting a luxury experience for clients, and welcomed Rana Das-Gupta as the new Medical Director, emphasizing his expertise in body fat reduction.